Home » Topics » BioWorld Science

BioWorld Science
RSS

Waking up sleeping Xs

Sep. 19, 2019

p38Gamma as a novel therapeutic target in human colorectal cancer

Sep. 19, 2019

EGPI-1 as a promising new anticancer agent that targets the eIF4E/eIF4G interface

Sep. 19, 2019

Mitochondria differ between cell types

Sep. 19, 2019

Methylation patterns, AI identify metastases

Sep. 19, 2019

Imotope shows promise in EAE model

Sep. 19, 2019

Aspartylglycosamine as a potential new biochemical marker of NGLY1-CDDG

Sep. 19, 2019

Ra's zilucoplan selected for evaluation in ALS platform trial

Sep. 18, 2019

Durect completes phase IIa trial of DUR-928 in alcoholic hepatitis

Sep. 18, 2019

Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy

Sep. 18, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...